Your browser doesn't support javascript.
loading
Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation.
Fernandes, Vanessa C; Golubeva, Volha A; Di Pietro, Giuliano; Shields, Cara; Amankwah, Kwabena; Nepomuceno, Thales C; de Gregoriis, Giuliana; Abreu, Renata B V; Harro, Carly; Gomes, Thiago T; Silva, Ricceli F; Suarez-Kurtz, Guilherme; Couch, Fergus J; Iversen, Edwin S; Monteiro, Alvaro N A; Carvalho, Marcelo A.
Afiliação
  • Fernandes VC; From the Instituto Nacional de Câncer, Programa de Pesquisa Clínica, Rio de Janeiro, Brazil 20231-050.
  • Golubeva VA; the Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612.
  • Di Pietro G; the Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612; the Universidade Federal de Sergipe, Campus São Cristóvão, Brazil 49100-000.
  • Shields C; the Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612.
  • Amankwah K; the Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612.
  • Nepomuceno TC; From the Instituto Nacional de Câncer, Programa de Pesquisa Clínica, Rio de Janeiro, Brazil 20231-050; the Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612.
  • de Gregoriis G; From the Instituto Nacional de Câncer, Programa de Pesquisa Clínica, Rio de Janeiro, Brazil 20231-050.
  • Abreu RBV; From the Instituto Nacional de Câncer, Programa de Pesquisa Clínica, Rio de Janeiro, Brazil 20231-050.
  • Harro C; the Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612; the Department of Cell Biology, Microbiology, College of Arts and Sciences, University of South Florida Cancer Biology Ph.D. Program, Tampa, Florida 33612.
  • Gomes TT; the Instituto Federal do Rio de Janeiro, Rio de Janeiro 20270-021, Brazil.
  • Silva RF; the Instituto Federal do Rio de Janeiro, Rio de Janeiro 20270-021, Brazil.
  • Suarez-Kurtz G; From the Instituto Nacional de Câncer, Programa de Pesquisa Clínica, Rio de Janeiro, Brazil 20231-050.
  • Couch FJ; the Department of Laboratory Medicine, Mayo Clinic, Rochester, Minnesota 55905.
  • Iversen ES; the Department of Statistics, Duke University, Durham, North Carolina 27710.
  • Monteiro ANA; the Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612. Electronic address: alvaro.monteiro@moffitt.org.
  • Carvalho MA; From the Instituto Nacional de Câncer, Programa de Pesquisa Clínica, Rio de Janeiro, Brazil 20231-050. Electronic address: marcelo.carvalho@ifrj.edu.br.
J Biol Chem ; 294(15): 5980-5992, 2019 04 12.
Article em En | MEDLINE | ID: mdl-30765603

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Modelos Moleculares / Proteína BRCA1 / Mutação de Sentido Incorreto Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Biol Chem Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Modelos Moleculares / Proteína BRCA1 / Mutação de Sentido Incorreto Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Biol Chem Ano de publicação: 2019 Tipo de documento: Article